L-DOPA
FDA Approved
Description
Levodopa, also known as L-DOPA, is a precursor to dopamine that can cross the blood-brain barrier and is converted into dopamine in the brain. It is used to manage symptoms of parkinsonism. It helps to alleviate motor symptoms.
Indications & Therapeutic Use
Parkinson's disease, rare parkinsonian syndrome due to neurodegenerative disease
Linked Diseases:
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
L-DOPA
| Generic Name | L-DOPA |
| Brands | 1 brand available |
| Active Ingredient | Levodopa |
| Drug Class | Parkinson's disease |
| Manufacturer | Merck |
| Dosage Forms | Tablet, Capsule |
| Medical Code | N04BA01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes